NYC Cancer Trial Delivers ‘Unheard-of’ Result: Complete Remission for Everyone
7th June 2022
A small NYC-led cancer trial has achieved a result reportedly never before seen – the total remission of cancer in all of its patients.
To be sure, the trial — led by doctors at Memorial Sloan Kettering and backed by drug maker GlaxoSmithKline — has only completed treatment of 12 patients, with a specific cancer in its early stages and with a rare mutation as well.
But the results, reported Sunday in the New England Journal of Medicine and the New York Times, were still striking enough to prompt multiple physicians to tell the paper they were believed to be unprecedented.